Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1999 • 11,707 citations

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

1998 • 5,217 citations

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

1988 • 4,727 citations

Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score

1985 • 4,508 citations

Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score

1985 • 3,694 citations

Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

1984 • 3,149 citations

Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level

2006 • 3,012 citations

Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

1984 • 2,828 citations

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

2004 • 2,260 citations

Viral hepatitis B

2003 • 1,771 citations

Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma

2002 • 1,212 citations

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

2000 • 940 citations

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

2011 • 595 citations

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

2010 • 565 citations

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

2008 • 550 citations

Chronic hepatitis B virus infection in Asian countries

2000 • 495 citations

Epidemiological characteristics and risk factors of hepatocellular carcinoma

1997 • 472 citations

Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

2010 • 465 citations

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

2010 • 441 citations

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1998 • 434 citations

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B

2009 • 328 citations

Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

2010 • 268 citations

Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma

2011 • 253 citations

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients

2005 • 193 citations

Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses

1994 • 143 citations

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection

2010 • 115 citations

The Natural Course of Hepatitis B Surface Antigen—Positive Chronic Active Hepatitis in Taiwan

1982 • 80 citations

Long-Term Nucleos(t)ide Analogues Therapy for Adults With Chronic Hepatitis B reduces the Risk of Long-Term Complications: a meta-analysis

2011 • 62 citations

Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection

2012 • 59 citations

Risk of hepatocellular carcinoma in patients with cirrhosis in Japan

1994 • 48 citations